期刊文献+

ICU呼吸道院内感染分析及对策 被引量:3

下载PDF
导出
摘要 目的总结ICU中引起呼吸道院内感染的原因。方法82例病例均在无菌的条件下经气道吸痰取样,对培养菌株进行判定分析。针对各种感染敏感药物进行分析。结果阳性标本216份,254株病原菌。以革兰氏阴性菌(G-)为主,又以铜绿假单胞菌占首位;革兰氏阳性菌(G+)以金黄色葡萄球菌为主,并有部分真菌感染。结论ICU中呼吸道院内感染发生率高,且菌群复杂,耐药菌群增多,应根据敏感药物进行治疗,必要时联合药物治疗及抢先治疗。
出处 《江西医药》 CAS 2009年第10期978-980,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献5

  • 1The Canadian Critical Care Trials Group. A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia. New Engl J Med,2006,355(25) :2619.
  • 2Pekka Ylipalosaaril, Tero I Ala-Kokko2,et al. Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study. Critical Care, 2006, 10:R66.
  • 3Castelli GP,Pognani C,Stuani A,Cita M,Paladini R. Central venous catheter replacement in the ICU: new site versus guidewire exchange. Minerva Anestesiol,2007,73(50):267.
  • 4罗燕萍,沈定霞,张军民,朱姝媛.嗜麦芽窄食单胞菌耐药性分析[J].军医进修学院学报,2000,21(2):138-140. 被引量:21
  • 5Golzn Y,Wolf MP.Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. An Int Med,2005,143(12):857.

二级参考文献8

  • 11,National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial disk suceptibility testings[M].NCCLS,1999,19(1):58.
  • 22,Jarlier V,Nicolas MH,Fournier G et al.Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae:hospital prevalence and susceptibility patterns[J].Rev Infect Dis,1988,10:867-878.
  • 33,Philippon A,Arlet G,Lagrange PH.Origin and impact of plasmid-mediated extended-spectrum β-lactamases[J].Eur J Clin Microbiol Infect Dis,1994,13:17-29.
  • 44,Phlleron NJ,Bradbury JF.Stenotrophomonas,a new bacterial genus for Xanthomonas maltophilia[J].Int J Syst Bateriol,1993,43:606-609.
  • 55,Bush K,Jacoby GA,Medeiros AA.A functional classification scheme for β-lactam and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995,39:1211-1233.
  • 66,National Committee for Clinical Laboratory Standards.MIC interpretive standards for Pseudomonas aeruginosa and other non-Enterabacteriaceae approved standard[J].NCCLS,1999,19(1):76-77.
  • 77,Poulos CD,Matsumura SO,Willey BM et al.In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilis[J].Antimiciob Agents Chemother,1995,39(10):2220-2223.
  • 88,Garcia Sanchez JE,Vazquez Lopez ML,Blazquez de Castro AM et al.Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients:case reports[J].J Chemother,1997,9(3):238-240.

共引文献20

同被引文献12

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部